Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Exagen (XGN) EPS (Basic) (2018 - 2026)

Exagen filings provide 9 years of EPS (Basic) readings, the most recent being -$0.17 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 15.0% to -$0.17 in Q1 2026 year-over-year; TTM through Mar 2026 was -$0.89, a 5.95% decrease, with the full-year FY2025 number at -$0.93, down 12.05% from a year prior.
  • EPS (Basic) hit -$0.17 in Q1 2026 for Exagen, up from -$0.2 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.16 in Q2 2024 to a low of -$0.86 in Q2 2022.
  • Median EPS (Basic) over the past 5 years was -$0.28 (2023), compared with a mean of -$0.35.
  • Biggest five-year swings in EPS (Basic): tumbled 126.32% in 2022 and later surged 67.44% in 2023.
  • Exagen's EPS (Basic) stood at -$0.83 in 2022, then surged by 62.65% to -$0.31 in 2023, then soared by 35.48% to -$0.2 in 2024, then dropped by 0.0% to -$0.2 in 2025, then increased by 15.0% to -$0.17 in 2026.
  • The last three reported values for EPS (Basic) were -$0.17 (Q1 2026), -$0.2 (Q4 2025), and -$0.31 (Q3 2025) per Business Quant data.